Evolva SA is a Switzerland-based biotechnology company specializing in the development and commercialization of nature-derived ingredients through precision fermentation and synthetic biology. The company engineers yeast and microbial strains to produce high-purity compounds that traditionally come from plants, offering a sustainable alternative to extraction from natural sources. Evolva’s technology platform focuses on strain optimization, fermentation scale-up and downstream purification to deliver consistent, traceable ingredients for a variety of end markets.
Key products developed by Evolva include nootkatone, a grapefruit-derived flavor and insect-repellent molecule; valencene, used in citrus flavor applications; and santalol, a fragrance ingredient found in sandalwood. The company has also advanced the fermentation-based production of stevia glycosides for sugar reduction and resveratrol for dietary supplements and cosmetics. By leveraging its R&D capabilities, Evolva aims to address supply-chain challenges and environmental concerns associated with traditional plant extraction.
Evolva serves customers worldwide across the flavors & fragrances, nutrition & health, cosmetics and agricultural sectors. It has entered strategic partnerships and supply agreements with companies in Europe, North America and Asia to bring its ingredients to market at commercial scale. The company maintains its headquarters in Reinach, Switzerland, and operates research and pilot facilities in key biotech hubs.
Founded in 2004, Evolva is publicly traded in the United States over-the-counter under the ticker ELVAF. The management team comprises professionals with backgrounds in industrial biotechnology, chemical engineering and consumer goods, guiding Evolva’s efforts to expand its portfolio of sustainable, nature-based ingredients.
AI Generated. May Contain Errors.
Free ELVAF Stock Alerts